Lite Strategy LITS
NASDAQ LITS
$1.16 +0.01 (+0.87%)
At close: Oct 19, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Selling, General & Administrative (2010 - 2026)

Updated

Lite Strategy (LITS) posted Selling, General & Administrative of $2.91 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 4.1% from $2.8 million a year earlier and up 6.4% from the prior quarter.

Analysis

Lite Strategy (LITS) Selling, General & Administrative (2010 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Lite Strategy's Selling, General & Administrative came in at $12.05 million, down 11.0% from FY2025.

  • Annual Selling, General & Administrative has declined for three consecutive fiscal years, with a five-year compound annual growth rate of -13.2% (FY2021 to FY2026).
  • In prior fiscal years, Lite Strategy's Selling, General & Administrative was $13.53 million in FY2025 (-41.9%), $23.3 million in FY2024 (-29.7%), $33.13 million in FY2023 (+8.5%) and $30.54 million in FY2022 (+25.1%).
  • Quarterly Selling, General & Administrative has run from a low of $2.41 million in fiscal Q3 2025 to a high of $9.97 million in fiscal Q4 2023 over five years.
  • On a year-over-year basis, Selling, General & Administrative has increased in each of the last three quarters, with an average decline of 22.4% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was fiscal Q4 2023, with growth of 72.7%; the weakest was fiscal Q2 2025, with a decline of 60.8%.
  • According to Business Quant data, Selling, General & Administrative for the three prior fiscal quarters was $2.74 million (Q3 2026), $3.31 million (Q2 2026) and $3.1 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 6.43 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 3.63 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 5.65 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 1.92 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 3.41 Bn
10 Lite Strategy 40.09 Mn 7.97 Mn - 2.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.91 Mn
Mar 31, 2026 2.74 Mn
Dec 31, 2025 3.31 Mn
Sep 30, 2025 3.10 Mn
Jun 30, 2025 2.80 Mn
Mar 31, 2025 2.41 Mn
Dec 31, 2024 3.14 Mn
Sep 30, 2024 5.19 Mn
Jun 30, 2024 4.14 Mn
Mar 31, 2024 4.61 Mn
Dec 31, 2023 8.02 Mn
Sep 30, 2023 6.53 Mn
Jun 30, 2023 9.97 Mn
Mar 31, 2023 7.18 Mn
Dec 31, 2022 8.50 Mn
Sep 30, 2022 7.49 Mn
Jun 30, 2022 5.77 Mn
Mar 31, 2022 8.93 Mn
Dec 31, 2021 7.93 Mn
Sep 30, 2021 7.91 Mn
API Access

Lite Strategy Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LITS&period=max&api_key=YOUR_API_KEY